Jiat Ling Poon

1.4k total citations
73 papers, 974 citations indexed

About

Jiat Ling Poon is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Pharmacy. According to data from OpenAlex, Jiat Ling Poon has authored 73 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Pharmacology and 9 papers in Pharmacy. Recurrent topics in Jiat Ling Poon's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (15 papers) and Diabetes Management and Education (12 papers). Jiat Ling Poon is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (15 papers) and Diabetes Management and Education (12 papers). Jiat Ling Poon collaborates with scholars based in United States, United Kingdom and Canada. Jiat Ling Poon's co-authors include Heather L. Gelhorn, Michael B. Nichol, Megan M. Ullman, Brenda Riske, Marion A. Koerper, Randall Curtis, Kathleen W. Wyrwich, Kathleen A. Johnson, Nadia N. Ahmad and Priscilla Auguste and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Annals of the Rheumatic Diseases.

In The Last Decade

Jiat Ling Poon

64 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiat Ling Poon United States 19 294 242 109 99 97 73 974
Julie Birt United States 22 260 0.9× 96 0.4× 226 2.1× 92 0.9× 76 0.8× 61 1.2k
Krista Payne United States 14 224 0.8× 32 0.1× 85 0.8× 107 1.1× 20 0.2× 21 893
Jonathan R. Korn United States 17 80 0.3× 123 0.5× 81 0.7× 49 0.5× 13 0.1× 37 855
Evan Kantor United States 10 74 0.3× 32 0.1× 166 1.5× 76 0.8× 233 2.4× 19 796
Jeng‐Yuan Chiou Taiwan 17 45 0.2× 119 0.5× 24 0.2× 59 0.6× 38 0.4× 64 823
David Phillippo United Kingdom 16 103 0.4× 22 0.1× 221 2.0× 66 0.7× 72 0.7× 29 1.1k
R Neame United Kingdom 10 51 0.2× 118 0.5× 51 0.5× 112 1.1× 51 0.5× 18 865
Grammati Sarri United States 14 47 0.2× 138 0.6× 47 0.4× 69 0.7× 11 0.1× 39 743
Kelly Hollis United States 17 78 0.3× 49 0.2× 18 0.2× 188 1.9× 70 0.7× 39 976
T. Michelle Brown United States 17 163 0.6× 17 0.1× 63 0.6× 69 0.7× 49 0.5× 46 862

Countries citing papers authored by Jiat Ling Poon

Since Specialization
Citations

This map shows the geographic impact of Jiat Ling Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiat Ling Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiat Ling Poon more than expected).

Fields of papers citing papers by Jiat Ling Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiat Ling Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiat Ling Poon. The network helps show where Jiat Ling Poon may publish in the future.

Co-authorship network of co-authors of Jiat Ling Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Jiat Ling Poon. A scholar is included among the top collaborators of Jiat Ling Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiat Ling Poon. Jiat Ling Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shinde, Shraddha, Sujatro Chakladar, Ellen B. Dennehy, et al.. (2025). Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity. Sleep Medicine. 134. 106719–106719.
2.
Mignot, Emmanuel, Mark S. Aloia, Dennis Hwang, et al.. (2024). Digital Measures Development: Lessons Learned from an Expert Workshop Addressing Cross-Therapeutic Area Measures of Sleep. SHILAP Revista de lepidopterología. 8(1). 132–139. 1 indexed citations
3.
Shinde, Shraddha, et al.. (2024). Understanding the impact of non-alcoholic steatohepatitis with metabolic comorbidities on adults: a real-world qualitative study. Current Medical Research and Opinion. 40(4). 665–676. 2 indexed citations
4.
Boye, Kristina S., Hélène Sapin, Jiat Ling Poon, et al.. (2024). Tirzepatide Improves HRQoL Compared to Insulin Lispro in Poorly Controlled Basal Insulin-treated Adults with Long-standing T2D (SURPASS-6). Diabetologie und Stoffwechsel. 19(S 01). S74–S74.
5.
Gudzune, Kimberly A., Lee M. Kaplan, Scott Kahan, et al.. (2024). Weight-Reduction Preferences Among OBSERVE Study Participants With Obesity or Overweight: Opportunities for Shared Decision-Making. Endocrine Practice. 30(10). 917–926. 3 indexed citations
8.
Gudzune, Kimberly A., Adam Stefański, Dachuang Cao, et al.. (2024). Association between weight reduction achieved with tirzepatide and quality of life in adults with obesity: Results from the SURMOUNT ‐1 study. Diabetes Obesity and Metabolism. 27(2). 539–550. 18 indexed citations
9.
Gelhorn, Heather L., Stephen Maher, Hélène Sapin, Jiat Ling Poon, & Kristina S. Boye. (2023). Estimating meaningful change for The Impact of Weight on Self-Perception (IW-SP) questionnaire among people with type 2 diabetes. Quality of Life Research. 32(12). 3359–3371. 2 indexed citations
10.
Ding, Ding, et al.. (2023). PP131 Health Technology Assessment Agencies’ Expectations Regarding Patient Experience Data in Europe. International Journal of Technology Assessment in Health Care. 39(S1). S87–S87.
11.
Cambron‐Mellott, M. Janelle, Jiat Ling Poon, Qianqian Wang, et al.. (2022). Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3601–3615.
12.
Poon, Jiat Ling, Eric S. Meadows, David A. Price, et al.. (2021). Use of Connected Pen as a Diagnostic Tool to Evaluate Missed Bolus Dosing Behavior in People with Type 1 and Type 2 Diabetes. Diabetes Technology & Therapeutics. 24(1). 61–66. 13 indexed citations
13.
Liu, Jingwen, et al.. (2020). Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey. BMJ Open. 10(9). e038462–e038462. 19 indexed citations
14.
Chen, Jieling, Magaly Perez‐Nieves, Erik Spaepen, et al.. (2020). An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany. Postgraduate Medicine. 132(8). 727–736.
15.
16.
Nowell, W. Benjamin, Jeffrey R. Curtis, David Curtis, et al.. (2019). Digital Tracking of Rheumatoid Arthritis Longitudinally (DIGITAL) Using Biosensor and Patient-Reported Outcome Data: Protocol for a Real-World Study. JMIR Research Protocols. 8(9). e14665–e14665. 15 indexed citations
17.
Tervonen, Tommi, Heather L. Gelhorn, Jiat Ling Poon, et al.. (2017). MCDA swing weighting and discrete choice experiments for elicitation of patient benefit‐risk preferences: a critical assessment. Pharmacoepidemiology and Drug Safety. 26(12). 1483–1491. 46 indexed citations
18.
Gelhorn, Heather L., et al.. (2016). Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan. Patient Preference and Adherence. Volume 10. 1337–1348. 30 indexed citations
19.
Gelhorn, Heather L., Jiat Ling Poon, Evan Davies, et al.. (2015). Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK. Patient Preference and Adherence. 9. 1611–1611. 47 indexed citations
20.
Poon, Jiat Ling, et al.. (2011). PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B. Value in Health. 14(3). A210–A210. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026